In addition, JAK2 exon 12 mutation in PV2, and a thrombopoietin receptor MPLW515L/K mutation in ET and myelofibrosis [17] are novel mutations that have been described in JAK2V617F mutation negative patients. The gene discussed is JAK2; the disease is essential thrombocythemia.